APA (7th ed.) Citation

Kähler, K. C., & Utikal, J. (2016). Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG “GERMELATOX survey”) versus melanoma recurrence to quantify patients’ relative values for adjuvant therapy. Medicine, 95(46), . https://doi.org/10.1097/MD.0000000000005375

Chicago Style (17th ed.) Citation

Kähler, Katharina C., and Jochen Utikal. "Preferences of German Melanoma Patients for Interferon (IFN) α-2b Toxicities (the DeCOG “GERMELATOX Survey”) Versus Melanoma Recurrence to Quantify Patients’ Relative Values for Adjuvant Therapy." Medicine 95, no. 46 (2016). https://doi.org/10.1097/MD.0000000000005375.

MLA (9th ed.) Citation

Kähler, Katharina C., and Jochen Utikal. "Preferences of German Melanoma Patients for Interferon (IFN) α-2b Toxicities (the DeCOG “GERMELATOX Survey”) Versus Melanoma Recurrence to Quantify Patients’ Relative Values for Adjuvant Therapy." Medicine, vol. 95, no. 46, 2016, https://doi.org/10.1097/MD.0000000000005375.